{"title":"COVID 19 孕妇临床严重程度对各孕期孕产妇和围产期结局的影响:前瞻性队列研究","authors":"Kubiszeski EH, Carmo MAMV, Carmo AV, Rosa Aancr, Carvalho AMB, Souza NS, Fontes CJ, Galera MF","doi":"10.9734/jammr/2024/v36i25367","DOIUrl":null,"url":null,"abstract":"Aims: To analyze the impact of clinical severity on maternal and perinatal outcomes across trimesters in coronavirus disease 2019 (COVID-19) pregnancies. \nStudy design: This was a prospective open cohort study of pregnant women with COVID-19 during the prenatal, delivery, postpartum periods from September 2020 to March 2022. \nMethodology: For data analysis, 132 pregnant women who had no pre-existing comorbidities or pregnancy-related complications at the beginning of the cohort were selected. Data related to COVID-19, demographic, clinical, obstetric, laboratory, ultrasound and birth outcomes were collected. \nResults: A total of 132 pregnant women with COVID-19 were followed up for 2237 women-week. Among them, 19.7% experienced maternal complications such as premature rupture of membranes (19.7%), premature delivery (10.6%), postpartum hemorrhage (8.3%), and preeclampsia (6.8%), or fetal/neonatal complications, including small for gestational age (9.1%), need for neonatal intensive care unit (9.1%), and acute fetal distress (6.1%). Having moderate/severe COVID-19 on prenatal care admission (hazard ratio (HR):3.75) and 95% confidence interval (CI95%):1.63; 8.61 or contracting the infection during the second (HR: 6.35; CI95%: 2.35; 17.17) or third trimester (HR:14.35; CI95%:4.85; 42.41) of pregnancy were significantly associated with these maternal complications. Similarly, having moderate/severe COVID-19 on prenatal care admission (HR:3.90; CI95%:1.48; 10.24) or contracting the infection during the second (HR:6.84; CI95%:2.05; 22.84) or third trimester (HR:22.4; CI95%:6.57; 76.33) of pregnancy were also associated with fetal/neonatal complications. \nConclusion: Pregnant women with COVID-19 have a higher risk of maternal or fetal/neonatal complications if they present with a moderate/severe COVID-19 on prenatal care admission or if the infection occurs in the second or third trimester of pregnancy.","PeriodicalId":506708,"journal":{"name":"Journal of Advances in Medicine and Medical Research","volume":"51 14","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of Clinical Severity on Maternal and Perinatal Outcome Across Trimesters in COVID 19 Pregnancies: A Prospective Cohort Study\",\"authors\":\"Kubiszeski EH, Carmo MAMV, Carmo AV, Rosa Aancr, Carvalho AMB, Souza NS, Fontes CJ, Galera MF\",\"doi\":\"10.9734/jammr/2024/v36i25367\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aims: To analyze the impact of clinical severity on maternal and perinatal outcomes across trimesters in coronavirus disease 2019 (COVID-19) pregnancies. \\nStudy design: This was a prospective open cohort study of pregnant women with COVID-19 during the prenatal, delivery, postpartum periods from September 2020 to March 2022. \\nMethodology: For data analysis, 132 pregnant women who had no pre-existing comorbidities or pregnancy-related complications at the beginning of the cohort were selected. Data related to COVID-19, demographic, clinical, obstetric, laboratory, ultrasound and birth outcomes were collected. \\nResults: A total of 132 pregnant women with COVID-19 were followed up for 2237 women-week. Among them, 19.7% experienced maternal complications such as premature rupture of membranes (19.7%), premature delivery (10.6%), postpartum hemorrhage (8.3%), and preeclampsia (6.8%), or fetal/neonatal complications, including small for gestational age (9.1%), need for neonatal intensive care unit (9.1%), and acute fetal distress (6.1%). Having moderate/severe COVID-19 on prenatal care admission (hazard ratio (HR):3.75) and 95% confidence interval (CI95%):1.63; 8.61 or contracting the infection during the second (HR: 6.35; CI95%: 2.35; 17.17) or third trimester (HR:14.35; CI95%:4.85; 42.41) of pregnancy were significantly associated with these maternal complications. Similarly, having moderate/severe COVID-19 on prenatal care admission (HR:3.90; CI95%:1.48; 10.24) or contracting the infection during the second (HR:6.84; CI95%:2.05; 22.84) or third trimester (HR:22.4; CI95%:6.57; 76.33) of pregnancy were also associated with fetal/neonatal complications. \\nConclusion: Pregnant women with COVID-19 have a higher risk of maternal or fetal/neonatal complications if they present with a moderate/severe COVID-19 on prenatal care admission or if the infection occurs in the second or third trimester of pregnancy.\",\"PeriodicalId\":506708,\"journal\":{\"name\":\"Journal of Advances in Medicine and Medical Research\",\"volume\":\"51 14\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Advances in Medicine and Medical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.9734/jammr/2024/v36i25367\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Advances in Medicine and Medical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/jammr/2024/v36i25367","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Impact of Clinical Severity on Maternal and Perinatal Outcome Across Trimesters in COVID 19 Pregnancies: A Prospective Cohort Study
Aims: To analyze the impact of clinical severity on maternal and perinatal outcomes across trimesters in coronavirus disease 2019 (COVID-19) pregnancies.
Study design: This was a prospective open cohort study of pregnant women with COVID-19 during the prenatal, delivery, postpartum periods from September 2020 to March 2022.
Methodology: For data analysis, 132 pregnant women who had no pre-existing comorbidities or pregnancy-related complications at the beginning of the cohort were selected. Data related to COVID-19, demographic, clinical, obstetric, laboratory, ultrasound and birth outcomes were collected.
Results: A total of 132 pregnant women with COVID-19 were followed up for 2237 women-week. Among them, 19.7% experienced maternal complications such as premature rupture of membranes (19.7%), premature delivery (10.6%), postpartum hemorrhage (8.3%), and preeclampsia (6.8%), or fetal/neonatal complications, including small for gestational age (9.1%), need for neonatal intensive care unit (9.1%), and acute fetal distress (6.1%). Having moderate/severe COVID-19 on prenatal care admission (hazard ratio (HR):3.75) and 95% confidence interval (CI95%):1.63; 8.61 or contracting the infection during the second (HR: 6.35; CI95%: 2.35; 17.17) or third trimester (HR:14.35; CI95%:4.85; 42.41) of pregnancy were significantly associated with these maternal complications. Similarly, having moderate/severe COVID-19 on prenatal care admission (HR:3.90; CI95%:1.48; 10.24) or contracting the infection during the second (HR:6.84; CI95%:2.05; 22.84) or third trimester (HR:22.4; CI95%:6.57; 76.33) of pregnancy were also associated with fetal/neonatal complications.
Conclusion: Pregnant women with COVID-19 have a higher risk of maternal or fetal/neonatal complications if they present with a moderate/severe COVID-19 on prenatal care admission or if the infection occurs in the second or third trimester of pregnancy.